Feifei Zhang
- Molecular Biology top 5%
- Cancer Research top 2%
- Molecular Medicine top 0.5%
- Epidemiology top 10%
- Endocrinology top 2%
- Topics
- Cancer-related molecular mechanisms research (17 papers)MicroRNA in disease regulation (10 papers)Antibiotic Resistance in Bacteria (9 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feifei Zhang
76 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 126
- Molecular Biology 1.3k
- Cancer Research 823
- Molecular Medicine 592
- Epidemiology 372
- Endocrinology 235
Countries citing papers authored by Feifei Zhang
This map shows the geographic impact of Feifei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Zhang more than expected).
Fields of papers citing papers by Feifei Zhang
This network shows the impact of papers produced by Feifei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Zhang. The network helps show where Feifei Zhang may publish in the future.
Co-authorship network of co-authors of Feifei Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Zhang. A scholar is included among the top collaborators of Feifei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Zhang. Feifei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 18 | |
| 11 | 4 | |
| 12 | 14 | |
| 13 | 86 | |
| 14 | 9 | |
| 15 | 14 | |
| 16 | 14 | |
| 17 | 51 | |
| 18 | 51 | |
| 19 | 74 | |
| 20 | 11 |
About Feifei Zhang
Feifei Zhang is a scholar working on Molecular Medicine, Cancer Research and Endocrinology, having authored 81 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (10 papers) and Antibiotic Resistance in Bacteria (9 papers). The work is most often cited by research in Molecular Medicine (592 citations), Cancer Research (823 citations) and Endocrinology (235 citations). Feifei Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hui Wang, Yawei Zhang, Xiaojuan Wang, Henan Li, Chunjiang Zhao, Qi Wang, Shuguang Li, Hongbin Chen, Ruobing Wang and Yuanjia Tang. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.